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ABSTRACT
Ekebergia capensis is an integral part of indigenous pharmacopeia in tropical Africa. The present study critically reviewed the ethnomedicinal 
uses, phytochemistry, and pharmacological properties of E. capensis. The keywords including E. capensis, its synonyms, English common names, 
ethnomedicinal uses, and phytochemistry and pharmacological properties of the species were searched using electronic databases such as ISI web 
of knowledge, ProQuest, science direct, OATD, Scopus, Open-thesis, PubMed, and Google Scholar. Pre-electronic literature search of conference 
papers, scientific articles, books, book chapters, dissertations, and theses was carried out at the University Library. Literature studies revealed that 
E. capensis is mainly used as herbal medicine against fever and malaria, gastrointestinal problems, pain, parasitic worms, reproductive problems 
in women, respiratory problems, and skin diseases. Phytochemical compounds identified from the species include alkaloids, anthraquinones, 
coumarins, flavonoids, glycoflavonoids, glycosides, iridoids, limonoids, polyphenols, phytosteroids, pregnane, saponins, tannins, and withanolides. 
Pharmacological studies revealed that E. capensis extracts and compounds have acetylcholinesterase-inhibitory, analgesic and anti-inflammatory, 
anthelmintic, antibacterial, antifungal, antigonococcal, antimycobacterial, antimycoplasmal, antihypertensive, antioxidant, antimalarial and 
antiplasmodial, antischistosomal, antitrypanosomal, and antiviral and cytotoxicity activities. Although pharmacological evaluations carried out so 
far have confirmed the potency of E. capensis crude extracts and compounds, detailed studies are required aimed at establishing the efficacy, clinical 
relevance, safety, and mechanisms of action of the plant extracts and compounds.
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INTRODUCTION
Ekebergia capensis Sparrm. (Family Meliaceae) is an important 
component of the indigenous pharmacopeia in South Africa where the 
bark, sometimes the leaves or roots are used as an emetic, vermifuge, 
abscesses, acne, acute gastritis, boils, chronic cough, dysentery, 
headache, heartburn, and scabies [1]. According to George et al. [2], 
E. capensis has potential as a commercial source of the compound 
limonoid ekebergin for vermifuge and emetic drugs. E. capensis is an 
integral part of the Materia Medica in South Africa, used regularly and 
included in the book “medicinal plants of South Africa” written by Van 
Wyk et al. [1]. Based on its wide application as herbal medicine, the bark 
of E. capensis is marketed as traditional medicine in informal herbal 
medicine markets and other informal markets in Gauteng and KwaZulu 
Natal provinces in South Africa [3,4]. According to Neuwinger [5], the 
leaves, roots, and stem bark of E. capensis are used as fish poison in the 
Democratic Republic of Congo (DRC) and Nigeria. The family Meliaceae 
is pantropical in distribution, consisting of trees and shrubs recorded 
in rainforests, with some taxa confined to seasonally dry forests, 
mangroves, and tropical woodlands [6]. At the present moment, about 
50 genera and 700 species are recognized in the family worldwide [6,7]. 
Close to a third of these species (223 species) are threatened with 
extinction, listed in the 2018 IUCN Red List of Threatened Species as 
critically endangered, vulnerable, or endangered [8]. Among these 
are Entandrophragma candollei Harms, Entandrophragma angolense 
(Welw.) C. DC., Entandrophragma utile (Dawe and Sprague) Sprague, 
Entandrophragma cylindricum (Sprague) Sprague, Khaya grandifoliola 
C. DC., Khaya anthotheca (Welw.) C. DC., K. madagascariensis Jum. and 
Perr., K. ivorensis A. Chev., and Khaya senegalensis (Descr.) A. Juss. which 
are listed as vulnerable or endangered [8] and used as timber and 
traditional medicines in tropical Africa [9]. In recent years, members 
of the Meliaceae family have attracted considerable attention as 
an important source of limonoids and tetranortriterpenoids with 
insecticidal, antifeedant, and other pharmacological properties [10]. It 
is within this context that the chemical composition, pharmacological 
properties, and medicinal uses of E. capensis were reviewed aimed at 
evaluating the therapeutic potential of the species.
BOTANICAL PROFILE OF E. CAPENSIS
The genus Ekebergia sparrm. is in honor of a Swedish physician and 
chemist, Captain Carl Gustaf Ekeberg (1716–1784), whose sponsorship 
in the 18th century made it possible for Anders Sparrman, the author 
of the genus and the species E. capensis to visit Africa [11,12]. The 
specific name “capensis” means “from the Cape” in reference to the 
Cape province in South Africa where the type specimen was collected 
from. The genus Ekebergia consists of four species globally, E. capensis, 
Ekebergia benguelensis Welw. ex C. DC., Ekebergia pterophylla (C. DC.) 
Hofmeyr, and Ekebergia pumila I. M. Johnst [11,13,14]. E. capensis is a 
semi-deciduous or evergreen, large to medium-sized tree growing up to 
100 cm in diameter and 35 m in height [11,12,15]. The bole is usually 
straight or sometimes crooked, branchless for up to 12 cm; stem may 
be swollen, buttressed and fluted in forests or short, and unfluted in 
open woodland [11]. The young stems are dotted circular leaf scars and 
whitish lenticels. Leaves are compound, alternate or crowded at the 
ends of branchlets. The leaflets are 3–7 pairs per leaf, glossy green in 
color, margin entire and may be waxy, with an asymmetric base, sessile, 
opposite, with a terminal leaflet and sometimes with a drip-tip [15]. 
Flowers are small, greenish-yellow, or white in color, sweetly scented, 
with male and female flowers on different trees. Fruits are fleshy and 
succulent, subglobose, pink to bright red in color when ripe [11]. The 
seeds are white in color and oval in shape; a fruit usually produces 2–4 
seeds [11,15].
E. capensis is widespread in tropical and subtropical Africa, from 
Senegal east to Eritrea and Ethiopia and south to Botswana, eastern 
South Africa and Swaziland (Fig. 1). E. capensis has been recorded 
in dry, Afromontane and riverine forests on well drained and deep 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i10.28816
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sandy soils at an altitude ranging from 600 m to 3000 m above sea 
level and different rainfall regimes ranging from 750 mm to 2000 mm 
per annum [16]. In the savanna woodland and wooded grassland, 
E. capensis has been recorded on termite mounds [15].
MEDICINAL USES OF E. CAPENSIS
The bark, fruits, leaves, roots, stem bark, and wood of E. capensis are 
used as remedies for human and animal diseases (Table 1). Information 
on medicinal uses of the species has been found in Cameroon, Ethiopia, 
South Africa, Kenya, Uganda, Nigeria, and Swaziland. Major diseases 
recorded in at least three countries include fever and malaria, 
gastrointestinal problems, pain, parasitic worms, reproductive 
problems in women, respiratory problems, and skin diseases (Fig. 2). 
In multi-therapeutic applications, the bark maceration of E. capensis 
is mixed with the bark of Diospyros lycioides Desf. and taken orally 
as an herbal medicine for blood in feces [17]. The bark decoction of 
E. capensis is mixed with roots of Euclea natalensis A. DC. and taken 
orally as an herbal medicine for cough, heartburn, and respiratory 
complaints [18].
PHYTOCHEMICAL AND NUTRITIONAL COMPOSITION OF  
E. CAPENSIS
Several phytochemical compounds and minerals have been identified 
from leaves, stems, roots, root, and stem bark of E. capensis (Table 2). 
Other phytochemical compounds identified from the bark, leaves, 
roots, seeds, stem bark, and twigs of E. capensis include anthraquinones, 
flavonoids, glycosides, iridoids, polyphenols, phytosteroids, saponins, 
tannins, and withanolides [48,55-57]. Total flavonoids, gallotannins, 
iridoids, phenolics, and condensed tannins content of various parts 
of E. capensis are shown in Table 3. Some of the phytochemical 
compounds isolated from E. capensis demonstrated various biological 
activities and these include antiplasmodial activities exhibited 
by compounds 8, 24 [58], 23, 41, and 42 [59], in vivo antimalarial 
activities exhibited by compound 24 [58], cytotoxic activities 
Fig. 1: Distribution of Ekebergia capensis in tropical Africa
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exhibited by compounds 23, 24, 26, and 43 [60], and toxicity activities 
demonstrated by compounds 9 and 10 [61].
PHARMACOLOGICAL ACTIVITIES OF E. CAPENSIS
Some of the pharmacological activities of E. capensis listed in 
literature include acetylcholinesterase-inhibitory [57], analgesic 
and anti-inflammatory [26,69,70], anthelmintic [55,71], 
antibacterial [25,51,56,72,73], antigonococcal [25,67], 
antimycobacterial  74], antimycoplasmal [47], antifungal [25,56,72,73], 
antihypertensive [19,75], antioxidant [27,57,68,76], antimalarial 
and antiplasmodial [33,34,58,59,77-79], antischistosomal [80], 
antitrypanosomal [81], and antiviral [25,60] and 
cytotoxicity [26,34,59,60,76,82-84] activities. These pharmacological 
activities of various parts of the species are summarized below.
Acetylcholinesterase inhibitory
Amoo et al. [57] evaluated acetylcholinesterase inhibitory properties 
of E. capensis using colorimetric assay with galanthamine at 20 µM as a 
positive control. Acetylcholinesterase inhibition (%) at 1.0 mg/ml was 
73.8%–89.7%.These results suggest that E. capensis extracts deserve 
further investigation as they may provide secondary metabolites which 
Fig. 2: Diseases treated by Ekebergia capensis in tropical Africa
Table 1: Medicinal uses of Ekebergia capensis
Medicinal use Parts of the plant used Country References
Monotherapeutic applications
Anthrax infection Leaves South Africa [19]
Blood purifier Leaves South Africa [19]
Blood pressure Leaves South Africa [19]
Cancer (breast, skin, and throat) Bark, fruits, and leaves Ethiopia and Kenya [20,21]
Charms and casting of spells (love charm, 
protection of homestead and ward off evil 
spirits)
Bark and stem South Africa and Swaziland [22-24]
Disinfectant Bark South Africa [23]
Emetic Bark and leaves South Africa and Swaziland [1,18,23-26]
Epilepsy Leaves Nigeria [27]
Ethnoveterinary medicine Bark, flowers, fruits, leaves, 
roots, and stems
Ethiopia and Kenya [28-32]
Exhaustion Bark South Africa [23]
Fever and malaria Bark, leaves, roots, and stem 
bark
Ethiopia, Kenya, Nigeria, 
and Uganda
[27,33-38]
Gastrointestinal problems (diarrhea, 
dysentery, gastritis, and stomach ache)
Bark, fruits, leaves, roots, and 
stem bark
Ethiopia, Kenya, South 
Africa, Swaziland, and 
Uganda
[1,21,24-26,36,37-40]
Health tonic Bark Kenya [34]
Heart problems (heartburn and heart 
problems)
Bark, leaves, and roots South Africa [1,12,18,19,23]
Liver complaints Leaves South Africa [19]
Mental problem Leaves South Africa [41]
Reproductive problems (induce labor, 
infertility, menstrual problems, and 
ovarian cyst)
Bark, stem bark, and wood Cameroon, Ethiopia, and 
South Africa
[23,42-44]
Pain (backache and headache, jaw 
swelling, and pain)
Bark, leaves, and stems Ethiopia, Kenya, and South 
Africa
[1,12,17,24-26,29,32,36,45,46]
Parasitic worms (intestinal worms) Bark, leaves, and stem bark Kenya, South Africa, and 
Swaziland
[1,12,23,24,47]
Respiratory problems (chest pains, cold, 
cough, respiratory complaints, and runny 
nose)
Bark, leaves, roots, and stem 
bark
Ethiopia, Kenya, South 
Africa, and Swaziland
[1,12,18,23,25,26,29,36,40,47-50]
Skin diseases (abscesses, acne, boils, 
scabies, and skin rash)
Bark, leaves, and roots Ethiopia, Kenya, and South 
Africa
[1,12,25,26,36,41,51-53]
Snakebite Leaves and roots Uganda [37]
Sores Bark South Africa [41]
Venereal diseases Bark, leaves, and roots Kenya and South Africa [25,26,54]
Vermifuge Leaves South Africa [1]
Weight loss Bark Ethiopia [32]
Multi-therapeutic applications
Blood in feces Bark maceration taken orally 
mixed with those of Diospyros 
lycioides Desf.
South Africa [17]
Cough, heartburn, and respiratory 
complaints
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Table 2: Phytochemical compounds identified from Ekebergia capensis





1 Ekeberginine NMR Stem bark [62]
Coumarins
2 Ekersenin NMR Stem bark [58,63]
3 4,6-dimethoxy-5-methylcoumarin NMR Stem bark [58]
4 7-hydroxy-6-methoxycoumarin NMR Wood [42]
5 Xanthoxyletin NMR Stem bark [62]
Glycoflavonoids
6 Kaempferol-3-O-β-D-glucopyranoside MS and NMR Leaves [59]
7 Quercetin-3-O-β-D-glucopyranoside MS and NMR Leaves [59]
Limonoids
8 7-deacetoxy-7-oxogedunin NMR Stem bark [58]
9 Capensolactones l MS and NMR Seeds [61]
10 Capensolactones 2 MS and NMR Seeds [61]
11 Capensolactones 3 MS and NMR Seeds [61]
12 Ekebergin NMR Seeds [64]
13 Methyl 3x-hydroxy-3-deoxyangolensate MS and NMR Seeds [61]
14 Methylangolensate NMR Stem bark [58]
15 Mexicanolide NMR Stem bark [58]
16 Proceranolide MS and NMR Leaves and stem bark [58,59]
Phenolic
17 Atraric acid NMR Bark [65]
Phytosterol
18 β-sitosterol NMR Bark and wood [42,65]
19 β-sitosterol oleate NMR Bark [65]
20 β-sitosterol palmitate NMR Bark [65]
Pregnane




NMR Bark, stem bark and wood [42,58,59,66]
23 2-hydroxymethyl-2,3,22,23-tetrahydroxy 
-6,10,15,19,23 -pentamethyl-6,10,14,18-tetracosatetraene
NMR Bark and stem bark [58,59,66]
24 3,11-dioxoolean-12-en-28-oic acid NMR Stem bark [58]
25 3-epi-oleanolic acid MS and NMR Bark, root bark, stem bark, and wood [42,58,59,65,66]
26 3-oxo-12β-hydroxy-oleanan-28,13β-olide MS and NMR Root bark and stem bark [58,59]
27 7-acetylneotrichilenone NMR Stem bark [58]
28 Ekeberins A MS and NMR Root bark and stem bark [58,59]
29 Ekeberins B NMR Stem bark [58]
30 Ekeberins C1 NMR Stem bark [58]
31 Ekeberins C2 NMR Stem bark [58]
32 Ekeberins C3 NMR Stem bark [58]
33 Ekeberins D1 NMR Stem bark [58]
34 Ekeberins D2 NMR Stem bark [58]
35 Ekeberins D3 NMR Stem bark [58]
36 Ekeberins D4 NMR Stem bark [58]
37 Ekeberins D5 NMR Stem bark [58]
38 Lupeol NMR Bark [65]
39 Melliferone NMR Stem bark [58]
40 Oleanolic acid NMR Bark and stem bark [58,66]
41 Oleanolic acid MS and NMR Bark, root bark, and stem bark [58,59,66]
42 Oleanolic acid MS and NMR Bark, root bark, stem bark, and wood [42,58,59,65,66]
43 Swietenolide NMR Stem bark [58]
Table 3: Total flavonoids, gallotannins, iridoids, phenolics, and condensed tannins content of Ekebergia capensis
Phytochemical composition Values Plant parts References
Condensed tannins (% leukocyanidin equivalents) 0.32–0.47 Bark and leaves [25]
Flavonoids (µg catechin equivalents/g dry weight) 1.48–4.84 Bark and leaves [25]
Gallotannin (µg gallic acid equivalents/g dry weight) 35.37–70.00 Bark and leaves [25]
Total condensed tannins (mg cyanidin chloride equivalents/g dry weight) 12.5 Leaf [67]
Total flavonoids (mg catechin equivalent/g dry weight) 22.8––26.8 Leaf [57,67]
Total iridoids (µg harpagoside equivalents/g dry weight) 547.6–2221.5 Leaves and twigs [57]
Total phenolics (mg gallic acid equivalents/g dry weight) 9.63–45.0 Brak, leaves and twigs [25,57,67,68]
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can act as natural acetylcholinesterase inhibitors required for the 
treatment of neurodegenerative disorders.
Analgesic and anti-inflammatory
William et al. [70] evaluated the analgesic activities of aqueous stem 
bark extracts of E. capensis in albino rats using a hot plate and tail 
immersion tests. Rats were administered with doses of 100 mg/kg 
and 200 mg/kg intraperitoneally, and a standard drug pentazocine 
10 mg/kg was used. The extract showed activities which were dose-
dependent, and the activities were comparable to that of pentazocine in 
the hot plate method but higher than pentazocine in the tail immersion 
method. At the dosage of 200 mg/kg body weight, the latency period 
increased from 21.4 min at pre-treatment to 48.2 min and 59.4 min and 
15 min and 30 min post-treatment, respectively. The result of extract 
on tail immersion test response showed that there were no significant 
changes in the time for tail withdrawal at all dosages of extract 
administered except at 100 mg/kg body weight and 200 mg/kg body 
weight where the time for tail withdrawal was significantly shorter 
than that of the pre-treatment [70]. Comparing reaction times obtained 
for animals treated with the extracts and the control values, it was 
apparent that the extracts caused prolongation of latency times, which 
is indicative of centrally mediated activity.
Jäger et al. [69] evaluated aqueous and ethanolic root extracts of E. capensis 
in an in vitro assay for cyclooxygenase (COX) inhibitors with indomethacin 
(0.5 µg) as the control. The ethanolic extract of E. capens is showed inhibition 
of 82% which was >66.5% inhibition exhibited by the indomethacin 
control. Based on these results, the RE might be a rationale for the 
ethnopharmacological claim that E. capensis possess anti-inflammatory 
properties. Mulaudzi et al. [26] evaluated the anti-inflammatory activities 
of dichloromethane, ethanol, petroleum ether, and water bark, and leaf 
extracts of E. capensis against the COX (COX-1 and COX-2) enzymes. 
All the solvent extracts showed moderate to high (40–90%) inhibition 
activity toward COX-1, and insignificant to high (<20–85%) inhibition 
activity toward COX-2 at 250 µg/ml and three further concentrations 
were evaluated at 31.25 µg/ml, 62.5 µg/ml, and 125 µg/ml to determine 
inhibitory concentration (IC50) values. Water bark extracts bark showed 
half maximal IC50 value of 0.01 µg/ml and 0.05 µg/ml toward COX-1 
and COX-2, respectively [26]. These results support the traditional use 
of E. capensis in managing inflammatory ailments and diseases such as 
abscesses and acne in South Africa [1,41,51,52], pain and swelling of jaws 
in Ethiopia [32,46], and sores in South Africa [41].
Anthelmintic
McGaw et al. [71] evaluated anthelmintic activities of hexane, ethanol 
and waterleaf extracts of E. capensis on the mortality and reproductive 
ability of the free-living nematode Caenorhabditis elegans in two 
different assays. All extracts exhibited activities at a concentration of 
2 mg/ml after the 7 day incubation period, with only water and ethanol 
extracts showing activities at a concentration of 1 mg/ml and after 
2 h incubation period, respectively [71]. Eguale et al. [55] evaluated 
anthelmintic activities of crude aqueous and hydroalcoholic extracts of 
the seeds of E. capensis on eggs and adult Haemonchus contortus. Both 
aqueous and hydroalcoholic extracts induced significant egg hatching 
inhibition with aqueous extract requiring maximum concentration of 
0.25mg/ml to induce 100% egg hatch inhibition while the hydroalcoholic 
extracts did not induce complete inhibition at the highest concentration 
tested of 2mg/ml. The aqueous extract induced 50% inhibition (ED50) 
at 0.06 mg/ml while the ED50 value of hydroalcoholic extract was 
1.03mg/ml. After 24 h of exposure of adult H. contortus to different 
concentrations of plant extracts, hydroalcoholic extracts produced 
motility or mortality of adult H. contortus to the level of 60% at a 
concentration of 8mg/ml while aqueous extract produced only 43.3% 
at the same concentration [55]. These findings are comparable to the 
standard, albendazole which killed the parasites in a dose-dependent 
manner, and all the worms were dead at a concentration of 0.5 mg/ml 
within 24 h [55]. These biological evaluations are of importance in 
the traditional use of E. capensis as herbal medicine against intestinal 
worms in Kenya, South Africa, and Swaziland [1,12,23,24,47].
Antibacterial
Rabe and Van Staden [51] evaluated antibacterial activities of water and 
methanol bark extracts of E. capensis against Staphylococcus aureus, 
Staphylococcus epidermis, Bacillus subtilis, Escherichia coli, and 
Klebsiella pneumoniae using the agar diffusion and dilution methods 
with neomycin as the positive control. The extracts showed activities 
against S. aureus, S. epidermis, and B. subtilis with minimum 
inhibition concentration (MIC) values ranging from 2.0 mg/ml 
to 4.0 mg/ml [51]. Ndukwe et al. [56] evaluated the antibacterial 
activities of methanol leaf, root, and stem bark extracts of E. capensis 
against B. subtilis, E. coli, Klebsiella, Pseudomonas, Salmonella 
typhi, and S. aureus using disc diffusion assay. The extracts showed 
activities with a zone of inhibition ranging from 5 mm to 23 mm 
and MIC value of 6.25 µg/ml [56]. Mulaudzi et al. [25] investigated 
the antibacterial effects of aqueous, acetone, dichloromethane, 
ethanol, methanol, and petroleum ether bark and leaf extracts of 
E. capensis against B. subtilis, E. coli, K. pneumoniae, and S. aureus 
using microdilution bioassay with neomycin as the positive control. 
The minimal microbicidal concentration (MMC) of the tested 
bacteria ranged from 0.39 mg/mL to 3.13 mg/mL [25]. Similarly, 
York et al. [72] assessed the antibacterial properties of aqueous and 
dichloromethane-methanol (1:1) leaf extracts of E. capensis against 
K. pneumoniae, Moraxella catarrhalis, Mycobacterium smegmatis, 
and S. aureus using microdilution assay with ciprofloxacin as the 
positive control. The extract showed activities with MIC values 
ranging from 1.33 mg/ml to 16.0 mg/ml [72]. Mabona et al. [73] 
evaluated antibacterial activities of aqueous and dichlomethane-
methanol (1:1) bark and leaf extracts of E. capensis using the 
microtiter plate dilution technique against dermatologically 
relevant pathogens such as Brevibacillus agri, Propionibacterium 
acnes, Pseudomonas aeruginosa, S. aureus, and S. epidermidis with 
ciprofloxacin as the positive control and acetone and dimethyl 
sulfoxide (DMSO) as negative controls. The extracts showed activities 
with MIC values ranging from 0.38 mg/mL to >16.00 mg/mL [73]. 
These antibacterial activities displayed by different extracts of E. 
capensis somehow confirm the species’ antibacterial potential and its 
usefulness in the treatment and management of bacterial infections 
such as boils in South Africa [1,41,51,52], diarrhea in Kenya 
and Uganda [36,37], dysentery in South Africa [25,26], stomach 
problems in Ethiopia [21,39], and venereal diseases in Kenya and 
South Africa [25,26,54].
Antigonococcal
Mulaudzi et al. [25] evaluated the antigonococcal activities of aqueous, 
acetone, dichloromethane, ethanol, methanol, and petroleum ether bark 
and leaf extracts of E. capensis against Neisseria gonorrhoeae through 
determination of clear zones of inhibition with ciprofloxacin and DMSO as 
positive and negative controls, respectively. E. capensis showed moderate 
to high activity with dichloromethane, ethanol, and petroleum ether 
extracts with percentage inhibition ranging from 45.0% to 96.0% [25]. 
Similarly, Vambe et al. [67] evaluated the antigonococcal activities of 
dichloromethane, methanol, and petroleum ether and waterleaf extracts 
of E. capensis against N. gonorrhoeae using microdilution and agar 
disk diffusion techniques with ciprofloxacin as the positive control. All 
extracts exhibited activities with MIC value of >2.5 mg/ml. The good 
antigonococcal activities exhibited by E. capensis extracts tested in this 
study could lead to the isolation of lead antigonococcal compounds.
Antimycobacterial
Lall and Meyer [74] evaluated antimycobacterial activities of 
acetone extract of E. capensis against a drug-sensitive strain of 
Mycobacterium tuberculosis (H37Rv) using the agar plate method. 
The activity of the extract was 0.5 mg/ml, and further evaluation 
was carried out using a rapid radiometric method to confirm the 
inhibitory activity. The extract exhibited MIC value of 0.1 mg/ml 
against the H37Rv strain. These antimycobacterial activities suggest 
that E. capensis extracts deserve further investigation as they may 
provide secondary metabolites which may lead to tuberculosis drug 
discovery.
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Antimycoplasmal
Kama-Kama et al. [47] evaluated antimycoplasmal activities 
of methanol-dichloromethane (1:1) and methanol stem bark extracts 
of E. capensis against Mycoplasma mycoides subsp. capri, five strains of 
M. mycoides subsp. mycoides and one strain of Mycoplasma capricolum 
subsp. Capricolum using broth microdilution assays. All the extracts 
showed activities with MIC values ranging from 0.13 mg/ml to 
0.15 mg/ml [47]. These findings suggest that E. capensis contains 
phytochemical compounds that might be useful for the treatment and 
management of respiratory diseases in ruminants.
Antifungal
Ndukwe et al. [56] evaluated the antifungal activities of methanol leaf, 
root, and stem bark extracts of E. capensis against Aspergillus niger 
and Candida albicans using disc diffusion assay. The extracts showed 
activities with a zone of inhibition ranging from 5 mm to 20 mm [56]. 
Mulaudzi et al. [25] evaluated the antifungal effects of aqueous, acetone, 
dichloromethane, ethanol, methanol, and petroleum ether bark and 
leaf extracts of E. capensis against C. albicans using microdilution 
bioassay with amphotericin as the positive control. The MIC value of 
the tested fungus ranged from 0.39 mg/mL to 6.3 mg/mL, while the 
minimum fungicidal concentration values ranged from 3.13 mg/mL to 
12.5 mg/mL [25]. Similarly, York et al. [72] assessed antifungal properties 
of aqueous and dichloromethane-methanol (1:1) leaf extracts of 
E. capensis against Cryptococcus neoformans using microdilution assay 
with amphotericin B as the positive control. The dichloromethane-
methanol (1:1) extract demonstrated the best activity with MIC value of 
0.40 mg/ml, while aqueous extract exhibited activities with MIC value 
of 16.0 mg/ml [72]. Mabona et al. [73] evaluated antifungal activities 
of aqueous and dichlomethane-methanol (1:1) bark and leaf extracts 
of E. capensis using the microtiter plate dilution technique against 
dermatologically relevant pathogens such as C. albicans, Microsporum 
canis, and Trichophyton mentagrophytes with amphotericin B as the 
positive control and acetone and DMSO as negative controls. The 
extracts showed activities with MIC values ranging from 1.0 mg/mL to 
16.00 mg/mL and noteworthy antifungal activities were displayed by 
dichlomethane-methanol bark extracts against C. albicans, M. canis, and 
T. mentagrophytes with MIC value of 1.0 mg/mL [73].
Antihypertensive
Duncan et al. [19] evaluated antihypertensive properties of ethanol 
and waterleaf extracts of E. capensis using the angiotensin-converting 
enzyme (ACE) assay. The water and ethanol extracts exhibited ACE 
inhibition rate of 26% and 37%, respectively [19]. Kamadyaapa 
et al. [75] evaluated the in vivo effects of E. capensis leaf ethanolic 
extracts on the blood pressure of anesthetized normotensive male 
Wistar rats and conscious weanling Dahl salt-sensitive (DSS) rats, 
which develop hypertension as they age. The authors assessed 
contractile or relaxant responses to extracts in the absence or presence 
of reference drugs in Wistar rat isolated aortic rings precontracted 
with methoxamine hydrochloride (10 µM). The extracts prevented the 
development of hypertension in weanling genetically hypertensive DSS 
rats and the in vivo reduction in blood pressure by the extract occurred 
without significant alterations in the heart rate, suggesting that the 
in vitro cardiovascular effects of the extract significantly contributed 
to the hypotensive effects. These findings showed that the hypotensive 
effect of the extract was in part mediated through modulation of total 
peripheral resistance of the vascular smooth muscles, as evidenced by 
the extract’s elicited dose-dependent vasorelaxations in endothelium-
intact and endothelium-denuded aortic ring preparations [75].
Antioxidant
Sofidiya et al. [68] evaluated antioxidant activities of leaf extracts of E. 
capensis using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical 
scavenging and reducing power assays. The extract showed a dose-
dependent increase in activities ranging from 81.0% to 96.5% inhibition 
on DPPH which was comparable to the activities of the reference 
α-tocopherol which showed 96.9%–97.9% inhibition on DPPH. 
Reducing power results of the extracts were also dose-dependent and 
comparable to the activities exhibited by the reference α-tocopherol [68]. 
Aladesanmi et al. [27] evaluated antioxidant activities of methanol 
leaf extracts of E. capensis using the DPPH free radical scavenging 
assay. The extract exhibited activities with half maximal effective 
concentration (EC50) value of 13.3 µg/ml which was comparable to EC50 
value of 14.2 µg/ml exhibited by rutin, a pure standard antioxidant 
compound [27]. Amoo et al. [57] evaluated the antioxidant activities 
of E. capensis using the DPPH free radical scavenging and β-carotene-
linoleic acid model assays after long-term storage in comparison 
with freshly collected materials. The extracts showed EC50 values of 
4.7 μg/ml–25.5 μg/ml [57]. Tagne et al. [76] evaluated the antioxidant 
activities of methanol bark extracts of E. capensis using the DPPH and 
nitric oxide radical scavenging assays. The extract showed activities 
with DPPH and nitric oxide exhibiting an IC50 value of 15.8 μg/mL and 
299μg/mL which was comparable to IC50 values of 22.7 μg/mL and 
108 μg/mL exhibited by the standard gallic acid and ascorbic acid, 
respectively. Tagne et al. [76] also evaluated the antioxidant activities 
of hexane, dichloromethane, ethyl acetate, butanol, and methanol bark 
extracts of E. capensis using DPPH radical scavenging assay. Hexane 
extracts showed no activity, while dichloromethane showed weak 
activity with an IC50 value of 366.6 μg/mL and ethyl acetate, butanol 
and methanol were active with IC50 values ranging from 14.0 μg/mL to 
20.2 μg/mL [76].
Antimalarial and antiplasmodial
Clarkson et al. [77] evaluated antiplasmodial activities of E. capensis 
aqueous, dichloromethane, dichloromethane-methanol (1:1) fruit and 
twig extracts against Plasmodium falciparum using the parasite lactate 
dehydrogenase assay. The dichloromethane-methanol (1:1) fruit extract 
showed promising activity while dichloromethane-methanol (1:1) 
twig extract showed weak activity with IC50 values of 10 µg/mL and 
18 µg/mL, respectively [77]. Muregi et al. [33] evaluated antiplasmodial 
activities of chloroform, ethyl acetate, and hexane and methanol leaf 
extracts of E. capensis using the [G-3H] hypoxanthine incorporation assay 
using chloroquine sensitive and resistant laboratory-adapted strains 
of P. falciparum as the test organism. The hexane extract exhibited 
no antiplasmodial activity, but chloroform, ethyl acetate, methanol, 
and water extracts gave good IC50 values (<5 µg/mL) suggesting that 
E. capensishas a high in vitro antiplasmodial activities. Murata et al. [58] 
evaluated antiplasmodial activities of compounds 8, 22, 23, 33, 34, 
35, 36, and 37 isolated from the stem bark of E. capensis against the 
chloroquine sensitive strain of P. falciparum. The compounds 8 and 23 
showed activities with IC50 values of 6 µM and 7 µM, respectively [58]. 
Irungu et al. [59] evaluated antiplasmodial activities of leaf and root 
extracts of E. capensis and compounds isolated from the species against 
the chloroquine sensitive (D6) and the chloroquine-resistant (W2) 
strains of P. falciparum. The leaf and root extracts, as well as compounds 
22, 23, 41, and 42 exhibited moderate activities against the D6 and 
W2 strains of P. falciparum with IC50 values ranging from 18.2 µM to 
82.7 µM [59].
Koch et al. [34] evaluated antimalarial activities of bark extracts of 
E. capensis against a chloroquine-sensitive (D6) strain of P. falciparum 
using a semiautomated microdilution technique. The extract showed 
activity with an IC50 value of 3.97 µg/ml. Muregi et al. [78] evaluated 
in vivo antimalarial activities of leaf, root, and stem bark extracts of 
E. capensis in mice against a chloroquine-tolerant Plasmodium berghei 
NK65, either alone or in combination with chloroquine. The extracts 
showed activities with parasitemia suppressions ranging from 14.8% 
to 33.3% when extract used alone and 37.9% to 59.1% when the 
extract is used in combination with chloroquine. The extracts gave a 
20.0–40.0% mouse survival when used alone and 20.0–75.0% when the 
extract is used in combination with chloroquine. In combination with 
chloroquine, the extracts showed better chemo-suppression as well as 
longer mouse survival suggesting synergistic interactions of the extract 
and chloroquine [78]. Chukwuma [79] evaluated toxicity of hexane and 
methanol leaf extracts of E. capensis by exposing the fourth instar larvae 
of Anopheles gambiae to different extract concentrations of 62.5 µg/mL 
to 1000 µg/mL using N,N-diethyl-3-methylbenzamide as a reference 
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insecticide. The hexane fraction displayed mortality at 0.63 mg/mL 
with LC50 value of 0.81 mg/mL which was comparable to the LC50 value 
of 1.1 mg/mL exhibited by N,N-diethyl-3-methylbenzamide, a reference 
insecticide [79]. Murata et al. [58] evaluated in vivo antimalarial activities 
of compounds 22 and 23 isolated from the stem bark of E. capensis in 
mice against artificially induced chloroquine-sensitive P. berghei NK 
65 using the 4-day suppressive protocol. Each mouse within a group 
received test compound at a dose of 100, 250, and 500 mg/kg body 
weight, once a day for 4 days using a metal catheter. The introduced 
group received a corresponding volume of distilled water. The 
compound 23 at a dose of 500 mg/kg showed moderate parasitemia 
suppression of 52.9% against P. berghei NK 65 in a mouse model [58]. 
Therefore, E. capensis extracts showed promising antimalarial and 
antiplasmodial activities and these findings corroborate the traditional 
usage of bark, leaves, roots, and stem bark as remedies against malaria 
in Ethiopia [38], Kenya [33-35], Nigeria [27], and Uganda [37].
Antischistosomal
Musili et al. [80] evaluated antischistosomal activities of aqueous 
leaf extracts of E. capensis against juvenile, immature adult, and adult 
worms of Schistosoma mansoni in infected Swiss albino mice. The 
mice were infected with 90 cercariae each and treated orally with 
varying doses of aqueous extracts of E. capensis at doses of 25 mg/kg, 
50 mg/kg, 100 mg/kg, 200 mg/kg, and 400 mg/kg at 2 weeks (juvenile 
worms), 4 weeks (immature worms), and 7 weeks (adult worms) post-
infection with praziquantel (PZQ) and artemether as positive controls 
while infected untreated group was used as negative controls [80]. The 
extracts showed significant dose-dependent percentage worm load 
reduction at different doses ranging from 100 mg/kg to 400 mg/kg and 
the extracts also significantly reduced liver and intestine egg load counts 
at doses ranging from 50 mg/kg to 400 mg/kg which was also dose-
dependent. These observed activities on both adult and juvenile worms 
of the parasite were comparable to results obtained using positive 
control drugs PZQ and artemether [80]. A similar trend was exhibited 
by PZQ and artemether as positive controls these findings show the 
potential use of E. capensis in the management of schistosomiasis.
Antitrypanosomal
Mokoka et al. [81] evaluated antitrypanosomal activities of 
dichloromethane-methanol root extracts of E. capensis against 
Trypanosoma brucei rhodesiense using serial dilution. The extract 
exhibited activity with IC50value of 1.36 µg/mL with a moderate 
selectivity index value of 24.3, indicating its selectivity towards killing 
the parasites with very little toxicity towards the myoblasts L-6 cells 
with an IC50 value of 33.0 µg/mL [81].
Antiviral
Bagla et al. [60] evaluated antiviral activities of hexane, dichloromethane, 
and methanol root extracts of E. capensis against canine distemper 
virus, canine parainfluenza virus-2, feline herpesvirus-1, and 
lumpy skin disease virus using virucidal and attachment assays. 
Dichloromethane and hexane extracts inhibited all viruses by at 
least 50%, and the extracts showed weak activities with EC50 values 
ranging from 30.9 µg/ml to 78.2 µg/ml with selectivity index values of 
<1 [60]. Mulaudzi et al. [25] evaluated anti-HIV activities of aqueous and 
methanol bark and leaf extracts of E. capensis using a non-radioactive 
HIV-1 reverse transcriptase (RT) colorimetric ELISA kit. The aqueous 
bark and leaf extracts as well as methanol leaf extract showed good HIV-
1 RT inhibition percentage (70%) at 1 mg/mL based on COX-assay, with 
bark and leaf water extracts exhibiting dose-dependent IC50 values of 
0.01±0.00 mg/mL while leaf methanol extract exhibited IC50 values of 
0.39±0.06 mg/mL [25].
Cytotoxicity
Tagne et al. [76] evaluated antiproliferative activities of methanol 
bark extracts of E. capensis on four cell line panels consisting of 
NCI-H460 (lung cancer), MCF7 (breast cancer), PC3 (prostate 
cancer), HeLa (cervix cancer cell), and normal cell 3T3 (mouse 
cervical cells) using the sulforhodamine-B assay. The extracts showed 
activity with half-maximal growth inhibition (GI50) values ranging 
from 13.5 µg/mL to 28.8 µg/mL which were comparable to GI50 
values of 0.02 µg/mL–0.70 µg/mL exhibited by the positive control 
doxorubicin [76]. Tagne et al. [76] evaluated antiproliferative activities 
of hexane, dichloromethane, ethyl acetate, butanol, and methanol 
bark extracts of E. capensis against NCI-H460, MCF7, and 3T3 using 
the sulforhodamine-B assay. The extracts exhibited activities with 
GI50 values ranging from 10.0 µg/mL to 52.0 µg/mL [76]. Elgorashi 
et al. [82] evaluated genotoxic activities of dichloromethane bark 
extract of E. capensis using the Ames assay with S. typhimurium strain 
TA98 and TA100, and VITOTOX® tests with and without metabolic 
activation. No genotoxic effects were demonstrated by the extracts. 
Taylor et al. [83] evaluated genotoxic activities of dichloromethane 
and methanol leaf extract of E. capensis using the cytochalasin B 
micronucleus test and alkaline comet assay in human white blood cells. 
The extract showed clastogenic and/or aneuploid activity although 
micronucleus frequencies were well below that found for the positive 
control mitomycin at 0.1 µg/mL. Reid et al. [84] evaluated mutagenic 
and antimutagenic activities of dichloromethane and methanol bark 
extract of E. capensis using the Salmonella or microsome mutagenicity 
assay (Ames) against S. typhimurium TA98 and TA100 bacterial strains 
in the presence and absence of metabolic activator S9. No mutagenic 
and antimutagenic effects were demonstrated by the extracts. Koch 
et al. [34] evaluated cytotoxicity activities of bark extracts of E. capensis 
using KB human oral epidermoid cancer cell line with vinblastine 
(median effective dose [ED50]=0.04 µg/ml). The extract lacked toxicity 
to KB cells with ED50 value >20.0 µg/ml and selectivity index value 
>5.1. Bagla et al. [60] evaluated the cytotoxicity activities of hexane, 
dichloromethane, acetone, and methanol root extracts of E. capensis 
using a colorimetric tetrazolium-based 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay. Dichloromethane 
and hexane showed activities with half-maximal cytotoxic 
concentration (CC50) values ranging from 2.5 µg/ml to 43.1 µg/ml with 
selectivity index values of <1. Mulaudzi et al. [26] evaluated genotoxicity 
activities of dichloromethane, ethanol, petroleum ether, and water bark 
and leaf extracts of E. capensis using the Ames test, with and without S9 
(metabolic activation) against S. typhimurium tester strain TA98. The 
Ames test revealed that all leaf extracts were non-mutagenic toward 
S. typhimurium strain TA98 but bark extracts induced 50.0 revertant 
colonies at 500 µg/ml and 50.0 µg/ml and there was no dose-dependent 
increase and; therefore, the extract could be classified as a weak 
mutagen [26]. Irungu et al. [59] evaluated the cytotoxicity activities of 
leaf and root extracts of E. capensis and compounds 6, 7, 16, 22, 23, 25, 
28, 41, and 42isolated from the species against the mammalian African 
monkey kidney (vero), mouse breast cancer (4T1), human larynx 
carcinoma (HEp2), and human breast cancer (MDA-MB-231) cell lines 
using MTT assay. The leaf and root extracts exhibited activities against 
vero, 4T1 and HEp2 with IC50 values ranging from 2.8 µM to 97.8 µM 
while compounds 42, 25, 23, and 22 showed activities with compound 
42 with the highest cytotoxicity with IC50 values of 1.4 µM and 13.3 µM 
against the HEp2 and 4T1 cells, respectively [59].
Uterotonic
Sewram et al. [42] evaluated the uterotonic activities of aqueous wood 
extracts of E. capensis using both pregnant and non-pregnant guinea 
pig uterine smooth muscle in vitro. The extract exhibited positive 
uterotonic activities. Sewram et al. [42] evaluated the uterotonic 
activities of compounds 25 and 42 isolated from E. capensis using both 
pregnant and non-pregnant guinea pig uterine smooth muscle in vitro. 
The results of this study show that compounds 25 and 42 possess 
varying degrees of agonist activity on uterine smooth muscle with 
minor changes in the molecular structure affecting its intrinsic activity 
on uterine muscle. The compound 25 was observed to mediate its effect 
through the cholinergic receptor [42].
Toxicity
Mulholland and Lourine [61] evaluated toxicity activities of hexane 
seed extract of E. capensis as well as compounds 9, 10, 11, and 13 
isolated from the seeds of using the brine shrimps lethality test. The 
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extracts at a concentration of 10 µg/ml, 100 µg/ml, and 1000 µg/ml, 
compounds 9 and 10 demonstrated moderate activities of 10% at the 
lowest concentration and 61%–80% at the highest concentration [61]. 
Based on these toxicity evaluations, it can be inferred that E. capensis 
has some potential toxicity and caution should be exercised when 
using the species as herbal medicine. These findings corroborate the 
traditional use of the species as a fish poison in DRC and Nigeria [5].
CONCLUSION
The present review summarizes the ethnomedicinal uses, 
phytochemistry, pharmacology, and toxicity of different extracts and 
compounds of E. capensis, one of several medicinal plants in tropical 
Africa [85,86]. Several phytochemical compounds including alkaloids, 
anthraquinones, coumarins, flavonoids, glycoflavonoids, glycosides, 
iridoids, limonoids, polyphenols, phytosteroids, pregnane, saponins, 
tannins, and withanoides have been identified from different plant 
parts of the species. In the past 20 years, research on E. capensis 
focused on evaluating acetylcholinesterase-inhibitory, analgesic 
and anti-inflammatory, anthelmintic, antibacterial, antifungal, 
antigonococcal, antimycobacterial, antimalarial and antimycoplasmal, 
antihypertensive, antioxidant, antiplasmodial, antiproliferative, 
antischistosomal, antitrypanosomal, antiviral and cytotoxicity activities 
of the different extracts, and compounds isolated from the species. 
However, there is not yet enough phytochemical and pharmacological 
data and clinical research on the majority of ethnomedicinal 
applications of the species. As revealed by the present review, the vast 
majority of the documented ethnopharmacological studies reported 
are in vitro. There is no doubt that these ethnopharmacological studies 
demonstrated a remarkable potential of E. capensis in the treatment 
of different human health problems. However, there are limitations 
associated with the in vitro studies. Therefore, future studies on the 
species should focus on the mechanism of action of the extracts as well 
as compounds isolated from the species, in vivo studies and evaluations 
of target-organ toxicity. Since E. capensis is also used in combination 
with other plant species in various herbal concoctions, there is a need 
for extensive research to evaluate synergistic effects of the different 
extracts or pure isolates to evaluate their ability to enhance the 
efficiency of the additive mixtures. There is no doubt that E. capensis 
is a valuable medicinal plant characterized by several phytochemical 
compounds and pharmacological activities; however, future clinical 
trials are necessary to clinically support the safety and efficacy of the 
concoctions prepared from the species.
ACKNOWLEDGMENTS
The author would like to express his gratitude to the National Research 
Foundation, South Africa and Govan Mbeki Research and Development 
Centre, University of Fort Hare for financial support to conduct this study.
AUTHORS’ CONTRIBUTIONS
The authors declare that this work was done by the author named in 
this article.
CONFLICTS OF INTEREST
No conflicts of interest are associated with this work.
REFERENCES
1. Van Wyk BE, Van Oudtshoorn B, Gericke N. Medicinal Plants of South 
Africa. Pretoria: Briza Publications; 2013.
2. George J, Laing MD, Drewes SE. Phytochemical research in South 
Africa. S Afr J Sci 2001;97:93-105.
3. Williams VL, Balkwill K, Witkowski ET. A lexicon of plants traded in 
the Witwatersrand umuthi shops, South Africa. Bothalia 2001;31:71-98.
4. Cunningham AB. African Medicinal Plants: Setting Priorities at the 
Interface between Conservation and Primary Health Care. Paris: People 
and Plants Working Paper 1, UNESCO; 1993.
5. Neuwinger HD. Plants used for poison fishing in tropical Africa. 
Toxicon 2004;44:417-30.
6. Pennington TD, Edwards KS. Meliaceae. In: Berry PE, Yatskievych K, 
Holst BK, editors. Flora of the Venezuelan Guayana
6. Liliaceae-Myrsinaceae. St. Louis: Missouri Botanical Garden; 
2001. p. 528-49.
7. Muellner AN, Samuel R, Chase MW, Coleman A. An evaluation of 
tribes and generic relationships in Melioideae (Meliaceae) based on 
nuclear ITS ribosomal DNA. Taxon 2008;57:98-108.
8. International Union for Conservation of Nature (IUCN), Meliaceae: 
2018 IUCN Red List of Threatened Species (2018). Available from: 
http://www.iucnredlist.org/search. [Last accessed on 2018 Jan 12].
9. Louppe D, Oteng-Amoako AA, Brink M. Plant resources of tropical 
Africa 7: Timbers 1. Leiden: PROTA Foundation, Backhuys 
Publishers; 2008.
10. Atawodi SE, Atawodi JC. Azadirachta indica (neem): A plant of 
multiple biological and pharmacological activities. Phytochem Rev 
2009;8:601-20.
11. Palmer E, Pitman P. Trees for Southern Africa Covering All Known 
Indigenous Species in Republic of South Africa, South West Africa, 
Botswana, Lesotho and Swaziland. Cape Town: A.A. Balkema; 1972.
12. Schmidt E, Lotter M, McCleland W. Trees and shrubs of Mpumalanga 
and Kruger National Park. Johannesburg: Jacana Media; 2002.
13. Pennington TD, Styles BT. A generic monograph of the Meliaceae. 
Blumea 1975;22:419-540.
14. Hyde M, Wursten B, Ballings P, Palgrave MC. Flora of Zimbabwe: Species 
Information: Ekebergia capensis Sparrm. (2018). Available from: https://
www.zimbabweflora.co.zw/speciesdata/species.php?species_ id=133540. 
[Last accessed on 2018 Apr 15].
15. Palgrave MC. Keith Coates Palgrave Trees of Southern Africa. Cape 
Town: Struik Publishers; 2002.
16. Mairura FS. Ekebergia capensis Sparrm. In: Louppe D, Oteng-
Amoako AA, Brink M, editors. Plant Resources of Tropical Africa 7: 
Timbers 1. Leiden: PROTA Foundation, Backhuys Publishers; 2008. 
p. 227-31.
17. Arnold HJ, Gulumian M. Pharmacopoeia of traditional medicine in 
Venda. J Ethnopharmacol 1984;12:35-74.
18. Bryant AT. Zulu Medicine and Medicine-Men. Cape Town: C. Struik 
Publishers; 1966.
19. Duncan AC, Jäger AK, van Staden J. Screening of Zulu medicinal plants 
for angiotensin converting enzyme (ACE) inhibitors. J Ethnopharmacol 
1999;68:63-70.
20. Ochwang’i DO, Kimwele CN, Oduma JA, Gathumbi PK, Mbaria JM, 
Kiama SG. Medicinal plants used in treatment and management of cancer 
in Kakamega County, Kenya. J Ethnopharmacol 2014;151:1040-55.
21. Tuasha N, Petros B, Asfaw Z. Medicinal plants used by traditional 
healers to treat malignancies and other human ailments in Dalle District, 
Sidama zone, Ethiopia. J Ethnobiol Ethnomed 2018;14:15.
22. Gerstner J. A preliminary checklist of Zulu names of plants with short 
notes. Bantu Stud 1941;15:277-301.
23. Hutchings A, Scott AH, Lewis G, Cunningham AB. Zulu Medicinal 
Plants: An Inventory. Pietermaritzburg: University of Natal Press; 1996.
24. Long C. Swaziland’s Flora: SiSwati names and uses (2005). Swaziland 
National Trust Commission, Mbambane. Available from: http://www.
sntc.org.sz/index.asp. [Last accessed on 2018 May 7].
25. Mulaudzi RB, Ndhlala AR, Kulkarni MG, Finnie JF, Van Staden J. 
Antimicrobial properties and phenolic contents of medicinal plants 
used by the Venda people for conditions related to venereal diseases. 
J Ethnopharmacol 2011;135:330-7.
26. Mulaudzi RB, Ndhlala AR, Kulkarni MG, Finnie JF, Van Staden J. Anti-
inflammatory and mutagenic evaluation of medicinal plants used by 
Venda people against venereal and related diseases. J Ethnopharmacol 
2013;146:173-9.
27. Aladesanmi AJ, Iwalewa EO, Adebajo AC, Akinkunmi EO, Taiwo BJ, 
Olorunmola FO, et al. Antimicrobial and antioxidant activities of some 
Nigerian medicinal plants. Afr J Tradit Complement Altern Med 
2007;4:173-84.
28. Njoroge GN, Bussmann RW. Herbal usage and informant consensus 
in ethno veterinary management of cattle diseases among the Kikuyus 
(Central Kenya). J Ethnopharmacol 2006;108:332-9.
29. Okello SV, Nyunja RO, Netondo GW, Onyango JC. Ethno botanical 
study of medicinal plants used by Sabaots of Mt. Elgon, Kenya. Afr J 
Tradit Complement Altern Med 2010;7:1-10.
30. Wanzala W, Takken W, Mukabana WR, Pala AO, Hassanali A. Ethno 
knowledge of Bukusu community on livestock tick prevention and 
control in Bungoma District, Western Kenya. J Ethnopharmacol 
2012;140:298-324.
31. Tekle Y. An ethno-veterinary botanical survey of medicinal plants 
in Kochore District of Gedeo Zone, Southern nations nationalities 
and peoples regional state (SNNPRs), Ethiopia. J Sci Innovative Res 
67
Asian J Pharm Clin Res, Vol 11, Issue 10, 2018, 59-68
 Maroyi 
2014;3:433-45.
32. Kewessa G, Abebe T, Demessie A. Indigenous knowledge on the use 
and management of medicinal trees and shrubs in Dale district, Sidama 
zone, Southern Ethiopia. Ethnobot Res Appl 2015;14:171-82.
33. Muregi FW, Chhabra SC, Njagi EN, Lang’at-Thoruwa CC, Njue WM, 
Orago AS, et al. Anti-plasmodial activity of some Kenyan medicinal 
plant extracts singly and in combination with chloroquine. Phytother 
Res 2004;18:379-84.
34. Koch A, Tamez P, Pezzuto J, Soejarto D. Evaluation of plants used 
for antimalarial treatment by the maasai of Kenya. J Ethnopharmacol 
2005;101:95-9.
35. Njoroge GN, Bussmann RW. Diversity and utilization of antimalarial 
ethnophytotherapeutic remedies among the Kikuyus (Central Kenya). 
J Ethnobiol Ethnomed 2006;2:8.
36. Gachathi M. Kikuyu Botanical Dictionary: A Guide to Plant Names, 
Uses and Culture Values. Nairobi: Tropical Botany Press; 2007.
37. Opio DR, Andama E, Kureh GT. Ethnobotanical survey of antimalarial 
plants in areas of Abukamola, Angeta, Oculokori and Omarari of 
Alebtong District in Northern Uganda. Eur J Med Plants 2017;21:1-14.
38. Suleman S, Tufa TB, Kebebe D, Belew S, Mekonnen Y, Gashe F, et al. 
Treatment of malaria and related symptoms using traditional herbal 
medicine in Ethiopia. J Ethnopharmacol 2018;213:262-79.
39. Regassa R. Assessment of indigenous knowledge of medicinal plant 
practice and mode of service delivery in Hawassa city, Southern 
Ethiopia. J Med Plant Res 2013;7:517-35.
40. Meragiaw M, Asfaw Z, Argaw M. The status of ethnobotanical 
knowledge of medicinal plants and the impacts of resettlement 
in Delanta, North Western Wello, Northern Ethiopia. Evid Based 
Complement Alternat Med 2016;2016:24.
41. Pujol J. Natur Africa: The herbalist handbook. Durban: Jean Pujol 
Natural Healers Foundation; 1990.
42. Sewram V, Raynor MW, Mulholland DA, Raidoo DM. The uterotonic 
activity of compounds isolated from the supercritical fluid extract of 
Ekebergia capensis. J Pharm Biomed Anal 2000;24:133-45.
43. Jiofack T, Fokunang C, Guedje N, Kemeuze V, Fongnzossie FE, 
Nkongmeneck BA, et al. Ethnobotanical uses of medicinal plants 
of two ethno ecological regions of Cameroon. Int J Med Med Sci 
2010;2:60-79.
44. Lulekal E, Asfaw Z, Kelbessa E, Van Damme P. Ethnomedicinal study 
of plants used for human ailments in Ankober District, North Shewa 
zone, Amhara Region, Ethiopia. J Ethnobiol Ethnomed 2013;9:63.
45. Mabogo DE. The Ethnobotany of the Vhavenda [M.S. thesis]: Pretoria: 
University of Pretoria; 1990.
46. Girmay T, Teshome Z. Assessment of traditional medicinal plants used 
to treat human and livestock ailments and their threatening factors 
in Gulomekeda District, Northern Ethiopia. Int J Emerg Trends Sci 
Technol 2017;4:5061-70.
47. Kama-Kama F, Midiwo J, Nganga J, Maina N, Schiek E, Omosa LK, 
et al. Selected ethno-medicinal plants from Kenya with in vitro activity 
against major African livestock pathogens belonging to the Mycoplasma 
mycoides cluster. J Ethnopharmacol 2016;192:524-34.
48. Amusan OO, Sukati NA, Dlamini PS, Sibandze FG. Some Swazi 
phytomedicines and their constituents. Afr J Biotechnol 2007;6:267-72.
49. York T, de Wet H, van Vuuren SF. Plants used for treating respiratory 
infections in rural Maputaland, KwaZulu-Natal, South Africa. 
J Ethnopharmacol 2011;135:696-710.
50. Zerabruk S, Yirga G. Traditional knowledge of medicinal plants in 
Gindeberet District, Western Ethiopia. S Afr J Bot 2012;78:165-9.
51. Rabe T, Van Staden J. Antibacterial activity of South African plants 
used for medicinal purposes. J Ethnopharmacol 1997;56:81-7.
52. Grierson DS, Afolayan AJ. An ethnobotanical study of plants used 
for the treatment of wounds in the Eastern Cape, South Africa. 
J Ethnopharmacol 1999;67:327-32.
53. Getaneh S, Girma Z. An ethnobotanical study of medicinal plants in 
debre libanos wereda, central Ethiopia. Afr J Plant Sci 2014;8:366-79.
54. Jeruto P, Too E, Mwamburi LA, Amuka O. An inventory of medicinal 
plants used to treat gynaecological obstetric-urino-genital disorders in 
South Nandi sub county in Kenya. J Nat Sci Res 2015;5:136-52.
55. Eguale T, Tilahun G, Gidey M, Mekonnen Y. In vitro anthelmintic 
activities of four Ethiopian medicinal plants against Haemonchus 
contortus. Pharmacol Online 2006;3:153-65.
56. Ndukwe IG, Habila JD, Bello IA, Adeleye EO. Phytochemical analysis 
and antimicrobial screening of crude extracts from the leaves, stem 
bark and root bark of Ekebergia senegalensis A. Juss. Afr J Biotechnol 
2006;5:1792-4.
57. Amoo SO, Aremu AO, Moyo M, Van Staden J. Antioxidant and acetyl 
cholinesterase-inhibitory properties of long-term stored medicinal 
plants. BMC Complem Altern Med 2012;12:87.
58. Murata T, Miyase T, Muregi FW, Naoshima-Ishibashi Y, 
Umehara K, Warashina T, et al. Antiplasmodial triterpenoids from 
Ekebergia capensis. J Nat Prod 2008;71:167-74.
59. Irungu BN, Orwa JA, Gruhnojic A, Fitzpatrick PA, Landberg G, 
Kimani F, et al. Constituents of the roots and leaves of Ekebergia 
capensis and their potential antiplasmodial and cytotoxic activities. 
Molecules 2014;19:14235-46.
60. Bagla VP, McGaw LJ, Eloff JN. The antiviral activity of six South 
African plants traditionally used against infections in ethno veterinary 
medicine. Vet Microbiol 2012;155:198-206.
61. Mulholland DA, Lourine SE. Limonoids from Ekebergia capensis. 
Phytochem 1998;47:1357-61.
62. Lontsi D, Ayafor JF, Sondengam BL, Connolly JD, Rycroft DS. The 
use of two-dimensional long-range δC/δH correlation in conjunction 
with the one-dimensional proton-coupled 13C NMR spectrum in the 
structural elucidation of ekeberginine, a new carbazole alkaloid from 
Ekebergiasenegalensis (Meliaceae). Tetrahedron Lett 1985;26:4249-52.
63. Okogun JI, Enyenihi VU, Ekong DE. Spectral studies on coumarins and 
the determination of the constitution of ekersenin by total synthesis. 
Tetrahedron 1978;34:1221-4.
64. Taylor DA. Ekebergin, a limonoid extractive from Ekebergia capensis. 
Phytochem 1981;20:2263-5.
65. Mulholland DA, Mahomed HA, Lourine S. A comparison of extractives 
from the bark of Ekebergia capensis and Ekebergia senegalensis. S Afr 
J Bot 1997;63:259-60.
66. Nishiyama Y, Moriyasu M, Ichimaru M, Tichibana Y, Kato A, 
Mathenge SG, et al. Acyclic triterpenoids from Ekebergia capensis. 
Phytochem 1996;42:803-7.
67. Vambe M, Aremu AO, Chukwujekwu JC, Finnie JF, Van Staden J. 
Antibacterial screening, synergy studies and phenolic content of seven 
South African medicinal plants against drug-sensitive and-resistant 
microbial strains. S Afr J Bot 2018;114:250-9.
68. Sofidiya MD, Odukoya OA, Familoni OB, Inya-Agha SI. Free radical 
scavenging activity of some Nigerian medicinal plant extracts. Pak J 
Biol Sci 2006;9:1438-41.
69. Jäger AK, Hutchings A, Van Staden J. Screening of Zulu medicinal 
plants for prostaglandin-synthesis inhibitors. J Ethnopharmacol 
1996;52:95-100.
70. William A, Ngulde SI, Tijjani MB, Malgwi BU, Sandabe UK. Analgesic 
activities of the aqueous extract of Ekebergia senegalensis A. Jussstem 
bark in albino rats. Continental J Pharmacol Toxicol Res 2013;6:17-21.
71. McGaw LJ, Jäger AK, Van Staden J. Antibacterial, anthelmintic and anti-
amoebic activity in South African medicinal plants. J Ethnopharmacol 
2000;72:247-63.
72. York T, Van Vuuren SF, de Wet H. An antimicrobial evaluation of plants 
used for the treatment of respiratory infections in rural Maputaland, 
KwaZulu-Natal, South Africa. J Ethnopharmacol 2012;144:118-27.
73. Mabona U, Viljoen A, Shikanga E, Marston A, van Vuuren S. 
Antimicrobial activity of Southern African medicinal plants with 
dermatological relevance: From an ethnopharmacological screening 
approach, to combination studies and the isolation of a bioactive 
compound. J Ethnopharmacol 2013;148:45-55.
74. Lall N, Meyer JJ. In vitro inhibition of drug-resistant and drug-sensitive 
strains of Mycobacterium tuberculosis by ethnobotanically selected 
South African plants. J Ethnopharmacol 1999;66:347-54.
75. Kamadyaapa DR, Gondwe MM, Moodley K, Ojewole JA, 
Musabayane CT. Cardiovascular effects of Ekebergia capensis Sparrm 
(Meliaceae) ethanolic leaf extract in experimental animal paradigms. 
Cardiovasc J Afr 2009;20:162-7.
76. Tagne RS, Telefo BP, Nyemb JN, Yemele DM, Njima SN, Goka SM, 
et al. Anticancer and antioxidant activities of methanol extracts and 
fractions of some Cameroonian medicinal plants. Asian Pac J Trop Med 
2014;7:s442-7.
77. Clarkson C, Maharaj VJ, Crouch NR, Grace OM, Pillay P, Matsabisa MG, 
et al. In vitro antiplasmodial activity of medicinal plants native to or 
naturalised in South Africa. J Ethnopharmacol 2004;92:177-91.
78. Muregi FW, Ishih A, Miyase T, Suzuki T, Kino H, Amano T, et al. 
Antimalarial activity of methanolic extracts from plants used in Kenyan 
ethnomedicine and their interactions with chloroquine (CQ) against a 
CQ-tolerant rodent parasite, in mice. J Ethnopharmacol 2007;111:190-5.
79. Chukwuma OC. Meliaceae plants and vector control of malaria: 
Larvicidal studies of Ekebergia senegalensis A Juss and Cedrela 
odorata Linn. Planta Med 2013;79:sl45.
80. Musili R, Muregi F, Mwatha J, Muriu D, M’rewa L, Kamau T, 
et al. Antischistosomal Activity of Azadirachta indica and Ekebergia 
capensis in Mice Infected with Schistosoma mansoni. Eur J Med Plant 
68
Asian J Pharm Clin Res, Vol 11, Issue 10, 2018, 59-68
 Maroyi 
2015;6:92-102.
81. Mokoka TA, Xolani PK, Zimmermann S, Hata Y, Adams M, 
Kaiser M, et al. Antiprotozoal screening of 60 South African plants, and 
the identification of the antitry panosomal germacranolides schkuhrin 
I and II. Planta Med 2013;79:1380-4.
82. Elgorashi EE, Taylor JL, Maes A, Van Staden J, De Kimpe N, Verschaeve L. 
Screening of medicinal plants used in South African traditional medicine 
for genotoxic effects. Toxicol Lett 2003;143:195-207.
83. Taylor JL, Elgorashi EE, Maes A, Gorp UV, De Kimpe N, Van Staden J, 
et al. Investigating the safety of plants used in South African traditional 
medicine: Testing for genotoxicity in the micronucleus and alkaline 
comet assays. Environ Mol Mutagenesis 2003;42:144-54.
84. Reid KA, Maes J, Maes A, Van Staden J, De Kimpe N, Mulholland DA, 
et al. Evaluation of the mutagenic and antimutagenic effects of South 
African plants. J Ethnopharmacol 2006;106:44-50.
85. Maroyi A. Dicoma anomala Sond: A review of its botany, 
ethnomedicine, phytochemistry and pharmacology. Asian J Pharm Clin 
Res 2018;11:70-7.
86. Ansari I, Patil DT. A brief review on phytochemical and pharmacological 
profile of Carissa spinarum L. Asian J Pharm Clin Res 2018;11:12-8.
